Michael D. Clayman is President and CEO of Flexion Therapeutics Inc. Currently has a direct ownership of 0 shares of FLXN, which is worth approximately $0. The most recent transaction as insider was on Nov 19, 2021, when has been sold 335,498 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $2,851,733. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Michael D. Clayman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Sale (or disposition) back to the issuer
$2,851,733 $8.5 p/Share
335,498 Reduced 100.0%
0 Common Stock
Jul 19 2021
SELL
Payment of exercise price or tax liability
-
13,859 Reduced 3.97%
334,981 Common Stock
Jun 21 2021
BUY
Grant, award, or other acquisition
$13,226 $7.78 p/Share
1,700 Added 0.48%
348,840 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
106,100 Added 22.15%
373,001 Common Stock
Feb 01 2021
SELL
Bona fide gift
-
21,099 Reduced 5.73%
347,140 Common Stock
Jan 28 2021
SELL
Payment of exercise price or tax liability
$108,559 $12.37 p/Share
8,776 Reduced 3.18%
266,901 Common Stock
Jan 27 2021
BUY
Grant, award, or other acquisition
-
119,500 Added 30.24%
275,677 Common Stock
Jan 08 2021
SELL
Bona fide gift
-
4,762 Reduced 1.28%
368,239 Common Stock
Jan 05 2021
SELL
Payment of exercise price or tax liability
-
2,530 Reduced 1.59%
156,177 Common Stock
Jul 08 2020
SELL
Bona fide gift
-
1,303 Reduced 0.81%
158,707 Common Stock
MDC

Michael D. Clayman

President and CEO
Burlington, MA

Track Institutional and Insider Activities on FLXN

Follow Flexion Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FLXN shares.

Notify only if

Insider Trading

Get notified when an Flexion Therapeutics Inc insider buys or sells FLXN shares.

Notify only if

News

Receive news related to Flexion Therapeutics Inc

Track Activities on FLXN